Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways

Journal of Leukocyte Biology

Volumn 95, Issue 4, 2014, Pages 587-598

  Ballesteros, Iván ^a   Cuartero, María I ^a   Pradillo, Jesús M ^a   de la Parra, Juan ^a   Pérez Ruiz, Alberto ^a   Corbí, Ángel ^b   Ricote, Mercedes ^c   Hamilton, John A ^d   Sobrado, Mónica ^e   Vivancos, José ^e   Nombela, Florentino ^e   Lizasoain, Ignacio ^a   Moro, María A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Lipoxin; Microglia; Phagocytosis; Resolution; Stroke

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CD36 ANTIGEN; COLONY STIMULATING FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTE; BRAIN; BRAIN CELL CULTURE; BRAIN INFARCTION; CELL SUSPENSION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; INFLAMMATION; MACROPHAGE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

LIPOXIN; MICROGLIA; PHAGOCYTOSIS; RESOLUTION; STROKE;

ANIMALS; ANTIGENS, CD36; ARACHIDONATE 5-LIPOXYGENASE; BRAIN ISCHEMIA; CELLS, CULTURED; HYPOGLYCEMIC AGENTS; INFLAMMATION; LIPOXINS; MICE; MICE, INBRED C57BL; NEUTROPHILS; PHAGOCYTOSIS; PPAR GAMMA; RATS; THIAZOLIDINEDIONES; UP-REGULATION;

EID: 84899843404     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0613326     Document Type: Article

References (52)

1. Kersten, S., Desvergne, B., Wahli, W. (2000) Roles of PPARs in health and disease. Nature 405, 421-424.
2. Jiang, C., Ting, A. T., Seed, B. (1998) PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
3. Marx, N., Schonbeck, U., Lazar, M. A., Libby, P., Plutzky, J. (1998) Peroxisome proliferator-activated receptor γ activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res. 83, 1097-1103.
4. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., Glass, C. K. (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82.
5. Glass, C. K., Saijo, K. (2010) Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 10, 365-376.
6. Landreth, G., Jiang, Q., Mandrekar, S., Heneka, M. (2008) PPARα agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics 5, 481-489.
7. Tontonoz, P., Spiegelman, B. M. (2008) Fat and beyond: the diverse biology of PPARγ. Annu. Rev. Biochem. 77, 289-312.
8. Pereira, M. P., Hurtado, O., Cardenas, A., Alonso-Escolano, D., Bosca, L., Vivancos, J., Nombela, F., Leza, J. C., Lorenzo, P., Lizasoain, I., Moro, M. A. (2005) The nonthiazolidinedione PPARα agonist L-796,449 is neuroprotective in experimental stroke. J. Neuropathol. Exp. Neurol. 64, 797-805.
9. Pereira, M. P., Hurtado, O., Cardenas, A., Bosca, L., Castillo, J., Davalos, A., Vivancos, J., Serena, J., Lorenzo, P., Lizasoain, I., Moro, M. A. (2006) Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J. Cereb. Blood Flow Metab. 26, 218-229.
10. Shimazu, T., Inoue, I., Araki, N., Asano, Y., Sawada, M., Furuya, D., Nagoya, H., Greenberg, J. H. (2005) A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36, 353-359.
11. Sundararajan, S., Gamboa, J. L., Victor, N. A., Wanderi, E. W., Lust, W. D., Landreth, G. E. (2005) Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130, 685-696.
12. Zhao, Y., Patzer, A., Herdegen, T., Gohlke, P., Culman, J. (2006) Activation of cerebral peroxisome proliferator-activated receptors γ promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J. 20, 1162-1175.
13. Luo, Y., Yin, W., Signore, A. P., Zhang, F., Hong, Z., Wang, S., Graham, S. H., Chen, J. (2006) Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. J. Neurochem. 97, 435-448.
14. Tureyen, K., Kapadia, R., Bowen, K. K., Satriotomo, I., Liang, J., Feinstein, D. L., Vemuganti, R. (2007) Peroxisome proliferator-activated receptor-γ agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem. 101, 41-56.
15. Sobrado, M., Pereira, M. P., Ballesteros, I., Hurtado, O., Fernandez-Lopez, D., Pradillo, J. M., Caso, J. R., Vivancos, J., Nombela, F., Serena, J., Lizasoain, I., Moro, M. A. (2009) Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARγ-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J. Neurosci. 29, 3875-3884.
16. Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., Evans, R. M. (2001) PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7, 48-52.
17. Motojima, K., Passilly, P., Peters, J. M., Gonzalez, F. J., Latruffe, N. (1998) Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue-and inducer-specific manner. J. Biol. Chem. 273, 16710-16714.
18. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H., Evans, R. M. (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93, 229-240.
19. Tontonoz, P., Nagy, L., Alvarez, J. G., Thomazy, V. A., Evans, R. M. (1998) PPARα promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252.
20. Moore, K. J., Rosen, E. D., Fitzgerald, M. L., Randow, F., Andersson, L. P., Altshuler, D., Milstone, D. S., Mortensen, R. M., Spiegelman, B. M., Freeman, M. W. (2001) The role of PPAR-γ in macrophage differentiation and cholesterol uptake. Nat. Med. 7, 41-47.
21. Asada, K., Sasaki, S., Suda, T., Chida, K., Nakamura, H. (2004) Antiinflammatory roles of peroxisome proliferator-activated receptor γ in human alveolar macrophages. Am. J. Respir. Crit. Care Med. 169, 195-200.
22. Greenberg, M. E., Sun, M., Zhang, R., Febbraio, M., Silverstein, R., Hazen, S. L. (2006) Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med. 203, 2613-2625.
23. Shimizu, K., Kobayashi, M., Tahara, J., Shiratori, K. (2005) Cytokines and peroxisome proliferator-activated receptor γ ligand regulate phagocytosis by pancreatic stellate cells. Gastroenterology 128, 2105-2118.
24. Savill, J. (1997) Apoptosis in resolution of inflammation. J. Leukoc. Biol. 61, 375-380.
25. Serhan, C. N., Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197.
26. Roszer, T., Menendez-Gutierrez, M. P., Lefterova, M. I., Alameda, D., Nunez, V., Lazar, M. A., Fischer, T., Ricote, M. (2011) Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor γ or retinoid X receptor γ deficiency. J. Immunol. 186, 621-631.
27. Romera, C., Hurtado, O., Botella, S. H., Lizasoain, I., Cardenas, A., Fernandez-Tome, P., Leza, J. C., Lorenzo, P., Moro, M. A. (2004) In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-α pathway. J. Neurosci. 24, 1350-1357.
28. Denes, A., Vidyasagar, R., Feng, J., Narvainen, J., McColl, B. W., Kauppinen, R. A., Allan, S. M. (2007) Proliferating resident microglia after focal cerebral ischaemia in mice. J. Cereb. Blood Flow Metab. 27, 1941-1953.
29. West, M. J., Slomianka, L., Gundersen, H. J. (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231, 482-497.
30. Esmann, L., Idel, C., Sarkar, A., Hellberg, L., Behnen, M., Moller, S., van Zandbergen, G., Klinger, M., Kohl, J., Bussmeyer, U., Solbach, W., Laskay, T. (2010) Phagocytosis of apoptotic cells by neutrophil granulocytes: diminished proinflammatory neutrophil functions in the presence of apoptotic cells. J. Immunol. 184, 391-400.
31. Stafslien, D. K., Vedvik, K. L., De Rosier, T., Ozers, M. S. (2007) Analysis of ligand-dependent recruitment of coactivator peptides to RXRα in a time-resolved fluorescence resonance energy transfer assay. Mol. Cell. Endocrinol. 264, 82-89.
32. Colton, C. A. (2009) Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 4, 399-418.
33. Nakamura, T., Yamamoto, E., Kataoka, K., Yamashita, T., Tokutomi, Y., Dong, Y. F., Matsuba, S., Ogawa, H., Kim-Mitsuyama, S. (2007) Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure. Stroke 38, 3016-3022.
34. Serhan, C. N., Chiang, N., Van Dyke, T. E. (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-361.
35. Ren, Y., Silverstein, R. L., Allen, J., Savill, J. (1995) CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181, 1857-1862.
36. Savill, J., Hogg, N., Ren, Y., Haslett, C. (1992) Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90, 1513-1522.
37. Silverstein, R. L., Febbraio, M. (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal. 2, re3.
38. Serghides, L., Kain, K. C. (2001) Peroxisome proliferator-activated receptor γ-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-α secretion by monocytes/macrophages. J. Immunol. 166, 6742-6748.
39. Escribano, L., Simon, A. M., Gimeno, E., Cuadrado-Tejedor, M., Lopez de Maturana, R., Garcia-Osta, A., Ricobaraza, A., Perez-Mediavilla, A., Del Rio, J., Frechilla, D. (2010) Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and τ pathology. Neuropsychopharmacology 35, 1593-1604.
40. Yamanaka, M., Ishikawa, T., Griep, A., Axt, D., Kummer, M. P., Heneka, M. T. (2012) PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. J. Neurosci. 32, 17321-17331.
41. Zhao, X., Sun, G., Zhang, J., Strong, R., Song, W., Gonzales, N., Grotta, J. C., Aronowski, J. (2007) Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor γ in microglia/macrophages. Ann. Neurol. 61, 352-362.
42. Campanella, M., Sciorati, C., Tarozzo, G., Beltramo, M. (2002) Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 33, 586-592.
43. Carson, M. J., Reilly, C. R., Sutcliffe, J. G., Lo, D. (1998) Mature microglia resemble immature antigen-presenting cells. Glia 22, 72-85.
44. Perego, C., Fumagalli, S., De Simoni, M. G. (2011) Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J. Neuroinflammation 8, 174.
45. Cho, S., Park, E. M., Febbraio, M., Anrather, J., Park, L., Racchumi, G., Silverstein, R. L., Iadecola, C. (2005) The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J. Neurosci. 25, 2504-2512.
46. Schilling, M., Besselmann, M., Muller, M., Strecker, J. K., Ringelstein, E. B., Kiefer, R. (2005) Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: an investigation using green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 196, 290-297.
47. Hamilton, J. A. (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8, 533-544.
48. Chiang, N., Serhan, C. N., Dahlen, S. E., Drazen, J. M., Hay, D. W., Rovati, G. E., Shimizu, T., Yokomizo, T., Brink, C. (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58, 463-487.
49. Schaldach, C. M., Riby, J., Bjeldanes, L. F. (1999) Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 38, 7594-7600.
50. Sato, O., Kuriki, C., Fukui, Y., Motojima, K. (2002) Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor α and γ ligands. J. Biol. Chem. 277, 15703-15711.
51. Ren, Y., Stuart, L., Lindberg, F. P., Rosenkranz, A. R., Chen, Y., Mayadas, T. N., Savill, J. (2001) Nonphlogistic clearance of late apoptotic neutrophils by macrophages: efficient phagocytosis independent of β 2 integrins. J. Immunol. 166, 4743-4750.
52. Uderhardt, S., Herrmann, M., Oskolkova, O. V., Aschermann, S., Bicker, W., Ipseiz, N., Sarter, K., Frey, B., Rothe, T., Voll, R., Nimmerjahn, F., Bochkov, V. N., Schett, G., Kronke, G. (2012) 12/15-Lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 36, 834-846.